Computational Approaches to Accelerating Novel Medicine and Better Patient Care from Bedside to Benchtop

Theodore Sakellaropoulos, Junguk Hur, Ioannis N. Melas, Ellen Y. Guo, Leonidas Alexopoulos, Mohammad Bohlooly, Jane P.F. Bai

Research output: Chapter in Book/Report/Conference proceedingConference contribution

1 Citation (Scopus)

Abstract

Some successes have been achieved in the war on cancer over the past 30 years with recent efforts on protein kinase inhibitors. Nonetheless, we are still facing challenges due to cancer evolution. Cancers are complex and heterogeneous due to primary and secondary mutations, with phenotypic and molecular heterogeneity manifested among patients of a cancer, and within an individual patient throughout the disease course. Our understanding of cancer genomes has been facilitated by advances in omics and in bioinformatics technologies; major areas in cancer research are advancing in parallel on many fronts. Computational methods have been developed to decipher the molecular complexity of cancer and to identify driver mutations in cancers. Utilizing the identified driver mutations to develop effective therapy would require biological linkages from cellular context to clinical implication; for this purpose, computational mining of biomedical literature facilitates utilization of a huge volume of biomedical research data and knowledge. In addition, frontier technologies, such as genome editing technologies, are facilitating investigation of cancer mutations, and opening the door for developing novel treatments to treat diseases. We will review and highlight the challenges of treating cancers, which behave like moving targets due to mutation and evolution, and the current state-of-the-art research in the areas mentioned above.

Original languageEnglish (US)
Title of host publicationAdvances in Protein Chemistry and Structural Biology
EditorsRossen Donev
PublisherAcademic Press Inc.
Pages147-179
Number of pages33
ISBN (Print)9780128047958
DOIs
StatePublished - Jan 1 2016

Publication series

NameAdvances in Protein Chemistry and Structural Biology
Volume102
ISSN (Print)1876-1623

Fingerprint

Medicine
Patient Care
Genes
Neoplasms
Protein Kinase Inhibitors
Bioinformatics
Computational methods
Mutation
Technology
Computational Biology
Research
Biomedical Research
Genome
Therapeutics

Keywords

  • Computation
  • Driver mutations
  • Genome editing
  • Tumor heterogeneity

ASJC Scopus subject areas

  • Structural Biology
  • Biochemistry

Cite this

Sakellaropoulos, T., Hur, J., Melas, I. N., Guo, E. Y., Alexopoulos, L., Bohlooly, M., & Bai, J. P. F. (2016). Computational Approaches to Accelerating Novel Medicine and Better Patient Care from Bedside to Benchtop. In R. Donev (Ed.), Advances in Protein Chemistry and Structural Biology (pp. 147-179). (Advances in Protein Chemistry and Structural Biology; Vol. 102). Academic Press Inc.. https://doi.org/10.1016/bs.apcsb.2015.09.005

Computational Approaches to Accelerating Novel Medicine and Better Patient Care from Bedside to Benchtop. / Sakellaropoulos, Theodore; Hur, Junguk; Melas, Ioannis N.; Guo, Ellen Y.; Alexopoulos, Leonidas; Bohlooly, Mohammad; Bai, Jane P.F.

Advances in Protein Chemistry and Structural Biology. ed. / Rossen Donev. Academic Press Inc., 2016. p. 147-179 (Advances in Protein Chemistry and Structural Biology; Vol. 102).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Sakellaropoulos, T, Hur, J, Melas, IN, Guo, EY, Alexopoulos, L, Bohlooly, M & Bai, JPF 2016, Computational Approaches to Accelerating Novel Medicine and Better Patient Care from Bedside to Benchtop. in R Donev (ed.), Advances in Protein Chemistry and Structural Biology. Advances in Protein Chemistry and Structural Biology, vol. 102, Academic Press Inc., pp. 147-179. https://doi.org/10.1016/bs.apcsb.2015.09.005
Sakellaropoulos T, Hur J, Melas IN, Guo EY, Alexopoulos L, Bohlooly M et al. Computational Approaches to Accelerating Novel Medicine and Better Patient Care from Bedside to Benchtop. In Donev R, editor, Advances in Protein Chemistry and Structural Biology. Academic Press Inc. 2016. p. 147-179. (Advances in Protein Chemistry and Structural Biology). https://doi.org/10.1016/bs.apcsb.2015.09.005
Sakellaropoulos, Theodore ; Hur, Junguk ; Melas, Ioannis N. ; Guo, Ellen Y. ; Alexopoulos, Leonidas ; Bohlooly, Mohammad ; Bai, Jane P.F. / Computational Approaches to Accelerating Novel Medicine and Better Patient Care from Bedside to Benchtop. Advances in Protein Chemistry and Structural Biology. editor / Rossen Donev. Academic Press Inc., 2016. pp. 147-179 (Advances in Protein Chemistry and Structural Biology).
@inproceedings{8a83a780e31d40f5a7649c11808f57d8,
title = "Computational Approaches to Accelerating Novel Medicine and Better Patient Care from Bedside to Benchtop",
abstract = "Some successes have been achieved in the war on cancer over the past 30 years with recent efforts on protein kinase inhibitors. Nonetheless, we are still facing challenges due to cancer evolution. Cancers are complex and heterogeneous due to primary and secondary mutations, with phenotypic and molecular heterogeneity manifested among patients of a cancer, and within an individual patient throughout the disease course. Our understanding of cancer genomes has been facilitated by advances in omics and in bioinformatics technologies; major areas in cancer research are advancing in parallel on many fronts. Computational methods have been developed to decipher the molecular complexity of cancer and to identify driver mutations in cancers. Utilizing the identified driver mutations to develop effective therapy would require biological linkages from cellular context to clinical implication; for this purpose, computational mining of biomedical literature facilitates utilization of a huge volume of biomedical research data and knowledge. In addition, frontier technologies, such as genome editing technologies, are facilitating investigation of cancer mutations, and opening the door for developing novel treatments to treat diseases. We will review and highlight the challenges of treating cancers, which behave like moving targets due to mutation and evolution, and the current state-of-the-art research in the areas mentioned above.",
keywords = "Computation, Driver mutations, Genome editing, Tumor heterogeneity",
author = "Theodore Sakellaropoulos and Junguk Hur and Melas, {Ioannis N.} and Guo, {Ellen Y.} and Leonidas Alexopoulos and Mohammad Bohlooly and Bai, {Jane P.F.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/bs.apcsb.2015.09.005",
language = "English (US)",
isbn = "9780128047958",
series = "Advances in Protein Chemistry and Structural Biology",
publisher = "Academic Press Inc.",
pages = "147--179",
editor = "Rossen Donev",
booktitle = "Advances in Protein Chemistry and Structural Biology",

}

TY - GEN

T1 - Computational Approaches to Accelerating Novel Medicine and Better Patient Care from Bedside to Benchtop

AU - Sakellaropoulos, Theodore

AU - Hur, Junguk

AU - Melas, Ioannis N.

AU - Guo, Ellen Y.

AU - Alexopoulos, Leonidas

AU - Bohlooly, Mohammad

AU - Bai, Jane P.F.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Some successes have been achieved in the war on cancer over the past 30 years with recent efforts on protein kinase inhibitors. Nonetheless, we are still facing challenges due to cancer evolution. Cancers are complex and heterogeneous due to primary and secondary mutations, with phenotypic and molecular heterogeneity manifested among patients of a cancer, and within an individual patient throughout the disease course. Our understanding of cancer genomes has been facilitated by advances in omics and in bioinformatics technologies; major areas in cancer research are advancing in parallel on many fronts. Computational methods have been developed to decipher the molecular complexity of cancer and to identify driver mutations in cancers. Utilizing the identified driver mutations to develop effective therapy would require biological linkages from cellular context to clinical implication; for this purpose, computational mining of biomedical literature facilitates utilization of a huge volume of biomedical research data and knowledge. In addition, frontier technologies, such as genome editing technologies, are facilitating investigation of cancer mutations, and opening the door for developing novel treatments to treat diseases. We will review and highlight the challenges of treating cancers, which behave like moving targets due to mutation and evolution, and the current state-of-the-art research in the areas mentioned above.

AB - Some successes have been achieved in the war on cancer over the past 30 years with recent efforts on protein kinase inhibitors. Nonetheless, we are still facing challenges due to cancer evolution. Cancers are complex and heterogeneous due to primary and secondary mutations, with phenotypic and molecular heterogeneity manifested among patients of a cancer, and within an individual patient throughout the disease course. Our understanding of cancer genomes has been facilitated by advances in omics and in bioinformatics technologies; major areas in cancer research are advancing in parallel on many fronts. Computational methods have been developed to decipher the molecular complexity of cancer and to identify driver mutations in cancers. Utilizing the identified driver mutations to develop effective therapy would require biological linkages from cellular context to clinical implication; for this purpose, computational mining of biomedical literature facilitates utilization of a huge volume of biomedical research data and knowledge. In addition, frontier technologies, such as genome editing technologies, are facilitating investigation of cancer mutations, and opening the door for developing novel treatments to treat diseases. We will review and highlight the challenges of treating cancers, which behave like moving targets due to mutation and evolution, and the current state-of-the-art research in the areas mentioned above.

KW - Computation

KW - Driver mutations

KW - Genome editing

KW - Tumor heterogeneity

UR - http://www.scopus.com/inward/record.url?scp=84951299809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951299809&partnerID=8YFLogxK

U2 - 10.1016/bs.apcsb.2015.09.005

DO - 10.1016/bs.apcsb.2015.09.005

M3 - Conference contribution

C2 - 26827605

AN - SCOPUS:84951299809

SN - 9780128047958

T3 - Advances in Protein Chemistry and Structural Biology

SP - 147

EP - 179

BT - Advances in Protein Chemistry and Structural Biology

A2 - Donev, Rossen

PB - Academic Press Inc.

ER -